4th Annual At the Crossroads Conference
Friday, Nov. 1, 2002   (4:00-7:00 pm)

Quick, patent your genome. That's the message that a California man, Salvador Dolly, is spreading to everyone who will listen. And he should know.

Unbeknownst to Dolly, a biotech company obtained a tissue sample and sequenced his DNA. After discovering that Dolly had a rare but natural genetic resistance to the HIV virus, the company patented Dolly’s genome. To make matters worse, when Dolly began selling blood samples to medical researchers, the genetics company sued him for patent infringement.

The case of NuGenEra, Inc. v. Dolly is fictitious, but nonetheless generated a judicial opinion and made the headlines. It is now on appeal to the United States Supreme Court.

We invite you to attend oral argument on November 1, 2002. For this proceeding only, Court will convene in the new Girardi Advocacy Center at Loyola Law School, 919 S. Albany St. Los Angeles.

This is an event you won't want to miss.